Cereno's HDAC inhibitor reduces risks from pulmonary arterial hypertension in phase 2 trial 0 30.09.2024 16:04 Fiercebiotech.com Cereno's HDAC inhibitor reduces risks from pulmonary arterial hypertension in phase 2 trial jwaldron Mon, 09/30/2024 - 09:04
